Loading...
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
SIMPLE SUMMARY: The prognosis and treatment of metastatic melanoma have changed substantially since the advent of target therapy and immune checkpoint inhibitors. Thus, strategies must be developed to identify responder patients, reduce toxicities, and investigate target and immune based therapy ide...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699774/ https://ncbi.nlm.nih.gov/pubmed/33233603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113456 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|